×
iBio develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, ...
Accelerating Drug Discovery Through AI and Machine Learning · About · Platform · Pipeline · Partnering · Media/Events · Careers · Investors · Contact ...
People also ask
... recombinant protein design. For more information, visit www.ibioinc.com. Contact: Stephen Kilmer iBio, Inc. Investor Relations (646) 274-3580. skilmer@ibioinc.
Access iBio Inc (IBIO) Investor Relations material, such as Live Earnings Calls, Transcripts, Slides, Reports, and Estimates using Quartr.